Facilitatory effect of vasopressin on the ischemic decrease of the CA1 presynaptic fiber spikes in rat hippocampal slices

Takeshi Tanaka, Yoshiyuki Shishido, Shigenobu Shibata, Shigenori Watanabe

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

We investigated the effects of vasopressin-related neuropeptides on the hypoxia/hypoglycemia (ischemia)-induced decrease of the CA1 potential presynaptic elicited by stimulation of Schaffer collaterals in rat hippocampal slices. Treatment with arginine-vasopressin (AVP) potentiated the ischemic decrease of the CA1 presynaptic potential. In contrast, a V1 receptor antagonist produced a dose-dependent neuroprotective effect, whereas a V2 receptor antagonist had no effect. The AVP-induced decrease of the CA1 presynaptic potential was completely blocked by simultaneous application of the V1 receptor antagonist. Because AVP4-9 is regarded as the major proteoplytic product of AVP in the rat brain, we examined its effect on the ischemic decrease of the CA1 presynaptic potential. Treatment with AVP4-9 produced a more marked reduction of the potential than treatment with AVP itself. The present study demonstrates that stimulation of the V1 receptor has a detrimental effect on the development of ihe ischemic damage whereas V1 receptor blockade has a neuroprotective effect, suggesting that AVP may potentiate ischemic neuronal deficits via V1 receptor stimulation.

Original languageEnglish
Pages (from-to)343-346
Number of pages4
JournalBrain Research
Volume644
Issue number2
DOIs
Publication statusPublished - 1994 May 2
Externally publishedYes

Fingerprint

Vasopressin Receptors
Vasopressins
Arginine Vasopressin
Neuroprotective Agents
Neuropeptides
Hypoglycemia
Hippocampus
Ischemia
Brain

Keywords

  • Hippocampus
  • Hypoxia/hypoglycemia
  • Ischemia
  • Presynaptic potential
  • Vasopressin

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Facilitatory effect of vasopressin on the ischemic decrease of the CA1 presynaptic fiber spikes in rat hippocampal slices. / Tanaka, Takeshi; Shishido, Yoshiyuki; Shibata, Shigenobu; Watanabe, Shigenori.

In: Brain Research, Vol. 644, No. 2, 02.05.1994, p. 343-346.

Research output: Contribution to journalArticle

Tanaka, Takeshi ; Shishido, Yoshiyuki ; Shibata, Shigenobu ; Watanabe, Shigenori. / Facilitatory effect of vasopressin on the ischemic decrease of the CA1 presynaptic fiber spikes in rat hippocampal slices. In: Brain Research. 1994 ; Vol. 644, No. 2. pp. 343-346.
@article{0b4cc52522d6431f8dd4e5618b864346,
title = "Facilitatory effect of vasopressin on the ischemic decrease of the CA1 presynaptic fiber spikes in rat hippocampal slices",
abstract = "We investigated the effects of vasopressin-related neuropeptides on the hypoxia/hypoglycemia (ischemia)-induced decrease of the CA1 potential presynaptic elicited by stimulation of Schaffer collaterals in rat hippocampal slices. Treatment with arginine-vasopressin (AVP) potentiated the ischemic decrease of the CA1 presynaptic potential. In contrast, a V1 receptor antagonist produced a dose-dependent neuroprotective effect, whereas a V2 receptor antagonist had no effect. The AVP-induced decrease of the CA1 presynaptic potential was completely blocked by simultaneous application of the V1 receptor antagonist. Because AVP4-9 is regarded as the major proteoplytic product of AVP in the rat brain, we examined its effect on the ischemic decrease of the CA1 presynaptic potential. Treatment with AVP4-9 produced a more marked reduction of the potential than treatment with AVP itself. The present study demonstrates that stimulation of the V1 receptor has a detrimental effect on the development of ihe ischemic damage whereas V1 receptor blockade has a neuroprotective effect, suggesting that AVP may potentiate ischemic neuronal deficits via V1 receptor stimulation.",
keywords = "Hippocampus, Hypoxia/hypoglycemia, Ischemia, Presynaptic potential, Vasopressin",
author = "Takeshi Tanaka and Yoshiyuki Shishido and Shigenobu Shibata and Shigenori Watanabe",
year = "1994",
month = "5",
day = "2",
doi = "10.1016/0006-8993(94)91701-9",
language = "English",
volume = "644",
pages = "343--346",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Facilitatory effect of vasopressin on the ischemic decrease of the CA1 presynaptic fiber spikes in rat hippocampal slices

AU - Tanaka, Takeshi

AU - Shishido, Yoshiyuki

AU - Shibata, Shigenobu

AU - Watanabe, Shigenori

PY - 1994/5/2

Y1 - 1994/5/2

N2 - We investigated the effects of vasopressin-related neuropeptides on the hypoxia/hypoglycemia (ischemia)-induced decrease of the CA1 potential presynaptic elicited by stimulation of Schaffer collaterals in rat hippocampal slices. Treatment with arginine-vasopressin (AVP) potentiated the ischemic decrease of the CA1 presynaptic potential. In contrast, a V1 receptor antagonist produced a dose-dependent neuroprotective effect, whereas a V2 receptor antagonist had no effect. The AVP-induced decrease of the CA1 presynaptic potential was completely blocked by simultaneous application of the V1 receptor antagonist. Because AVP4-9 is regarded as the major proteoplytic product of AVP in the rat brain, we examined its effect on the ischemic decrease of the CA1 presynaptic potential. Treatment with AVP4-9 produced a more marked reduction of the potential than treatment with AVP itself. The present study demonstrates that stimulation of the V1 receptor has a detrimental effect on the development of ihe ischemic damage whereas V1 receptor blockade has a neuroprotective effect, suggesting that AVP may potentiate ischemic neuronal deficits via V1 receptor stimulation.

AB - We investigated the effects of vasopressin-related neuropeptides on the hypoxia/hypoglycemia (ischemia)-induced decrease of the CA1 potential presynaptic elicited by stimulation of Schaffer collaterals in rat hippocampal slices. Treatment with arginine-vasopressin (AVP) potentiated the ischemic decrease of the CA1 presynaptic potential. In contrast, a V1 receptor antagonist produced a dose-dependent neuroprotective effect, whereas a V2 receptor antagonist had no effect. The AVP-induced decrease of the CA1 presynaptic potential was completely blocked by simultaneous application of the V1 receptor antagonist. Because AVP4-9 is regarded as the major proteoplytic product of AVP in the rat brain, we examined its effect on the ischemic decrease of the CA1 presynaptic potential. Treatment with AVP4-9 produced a more marked reduction of the potential than treatment with AVP itself. The present study demonstrates that stimulation of the V1 receptor has a detrimental effect on the development of ihe ischemic damage whereas V1 receptor blockade has a neuroprotective effect, suggesting that AVP may potentiate ischemic neuronal deficits via V1 receptor stimulation.

KW - Hippocampus

KW - Hypoxia/hypoglycemia

KW - Ischemia

KW - Presynaptic potential

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=0028220695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028220695&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(94)91701-9

DO - 10.1016/0006-8993(94)91701-9

M3 - Article

C2 - 8050047

AN - SCOPUS:0028220695

VL - 644

SP - 343

EP - 346

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -